OncoSec Medical Incorporated
ONCS
ONCS was delisted on the 23rd of June, 2023.
20 hedge funds and large institutions have $4.28M invested in OncoSec Medical Incorporated in 2016 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 8 closing their positions.
23% less funds holding
Funds holding: 26 → 20 (-6)
33% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 6
43% less capital invested
Capital invested by funds: $7.47M → $4.28M (-$3.18M)
75% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 8
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$84K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$23K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$6.4K |
| 4 |
JP Morgan Chase
New York
|
+$1.28K |
| 5 |
Citigroup
New York
|
+$426 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$219K |
| 2 |
Nomura Holdings
Tokyo,
Japan
|
-$46K |
| 3 |
SIM
Spark Investment Management
New York
|
-$30K |
| 4 |
MLM
Mount Lucas Management
Newtown,
Pennsylvania
|
-$24K |
| 5 |
EDRH
Edmond de Rothschild Holding
Chambesy,
Switzerland
|
-$15.3K |
ONCS Hedge Fund Activity: Q1 2016 in Review
20 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in OncoSec Medical Incorporated (ONCS) for Q1 2016, worth a combined $4.28M — down 43% from $7.47M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of ONCS and 2 opened new positions — a net loss of 6 holders — while 6 trimmed existing stakes and 4 added.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $84K. The largest seller was Sabby Management, cutting an estimated $219K.
- 20 institutional investors held OncoSec Medical Incorporated (ONCS) as of Q1 2016, down from 26 in Q4 2015.
- Funds reported $4.28M of OncoSec Medical Incorporated stock for Q1 2016, down 43% quarter-over-quarter.
- 2 funds opened new OncoSec Medical Incorporated positions in Q1 2016 and 8 closed out, a net change of -6 holders.
- The largest OncoSec Medical Incorporated buyer in Q1 2016 was Renaissance Technologies, an estimated $84K added.
- The largest OncoSec Medical Incorporated seller in Q1 2016 was Sabby Management, an estimated $219K sold.
Based on aggregated 13F filings for Q1 2016.